Order Article Reprints

Pongamnuaykrit M, Tantiworawit A, Niprapan P, Punnachet T, Hantrakun N, Piriyakhuntorn P, Rattanathammethee T, Hantrakool S, Chai-Adisaksopha C, Rattarittamrong E, et al. The Efficacy and Safety of Deferasirox Monotherapy as a Second-Line Treatment in Transfusion-Dependent Thalassemia with Iron Overload. Journal of Clinical Medicine. 2025; 14(17):6212. https://doi.org/10.3390/jcm14176212

Pongamnuaykrit, Manatchaya, Adisak Tantiworawit, Piangrawee Niprapan, Teerachat Punnachet, Nonthakorn Hantrakun, Pokpong Piriyakhuntorn, Thanawat Rattanathammethee, Sasinee Hantrakool, Chatree Chai-Adisaksopha, Ekarat Rattarittamrong, and et al. 2025. "The Efficacy and Safety of Deferasirox Monotherapy as a Second-Line Treatment in Transfusion-Dependent Thalassemia with Iron Overload" Journal of Clinical Medicine 14, no. 17: 6212. https://doi.org/10.3390/jcm14176212

Pongamnuaykrit, M., Tantiworawit, A., Niprapan, P., Punnachet, T., Hantrakun, N., Piriyakhuntorn, P., Rattanathammethee, T., Hantrakool, S., Chai-Adisaksopha, C., Rattarittamrong, E., Norasetthada, L., & Charoenkwan, P. (2025). The Efficacy and Safety of Deferasirox Monotherapy as a Second-Line Treatment in Transfusion-Dependent Thalassemia with Iron Overload. Journal of Clinical Medicine, 14(17), 6212. https://doi.org/10.3390/jcm14176212